• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.43% Nasdaq Up 0.77%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    103.96 Down 1.07(1.02%) 10:31AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:105.03
    Open:105.12
    Bid:104.15 x 1000
    Ask:104.18 x 300
    1y Target Est:122.58
    Beta:1.18
    Next Earnings Date: 3-Feb-15GILD Earnings announcement
    Day's Range:103.73 - 105.50
    52wk Range:63.50 - 116.83
    Volume:2,722,284
    Avg Vol (3m):17,487,400
    Market Cap:156.84B
    P/E (ttm):18.52
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GILD

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 1.02%156.84B
    GSKUp 0.60%109.21B
    PFEDown 0.80%203.76B
    RHHBYDown 1.46%N/A

    Key Statistics

    Forward P/E (1 yr):10.57
    P/S (ttm):7.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.90
    Quarterly EPS Est (Dec-14) :2.20
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback